Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
471 studies found for:    Open Studies | "Ovarian Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Ovarian Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting KOrean Borderline Ovarian Tumor (KOBOT) Registry
Condition: Ovarian Neoplasms
Intervention:
2 Recruiting Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors
Condition: Ovarian Neoplasms
Intervention: Procedure: Abnormal Ovarian Ultrasound
3 Recruiting The SOCQER-2 Study Surgery in Ovarian Cancer - Quality of Life Evaluation Research
Condition: Ovarian Neoplasms
Intervention: Other: Observational cohort
4 Recruiting Use of Regorafenib in Recurrent Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: Regorafenib
5 Recruiting Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)
Condition: Ovarian Cancer
Intervention: Drug: pazopanib in combination with weekly topotecan
6 Recruiting Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer
Conditions: Ovarian Cancer;   Ovarian Neoplasms
Interventions: Drug: 18F-EF5 PET/CT scan;   Procedure: Optional biopsy
7 Not yet recruiting Phase Ib Study of Chiauranib in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Chiauranib
8 Recruiting A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Pembrolizumab;   Drug: Gemcitabine;   Drug: Cisplatin
9 Recruiting An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery
Condition: Ovary Cancer
Interventions: Drug: EC1456;   Drug: 99mTc-Etarfolatide
10 Not yet recruiting Improving Quality of Care for Patients With Recurrent Ovarian Cancer
Conditions: Ovarian Neoplasms;   Quality of Life
Intervention: Other: Questionnaires
11 Not yet recruiting Inherited Susceptible Genes Among Epithelial Ovarian Cancer
Conditions: Ovarian Neoplasm Epithelial;   Hereditary Breast and Ovarian Cancer Syndrome
Intervention:
12 Recruiting Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: PET/CT(3hours]
13 Recruiting Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: ovarian cancer surgery
14 Recruiting Writing About Experiences With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Writing about ovarian cancer
15 Not yet recruiting Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy
Condition: Ovarian Cancer
Interventions: Procedure: Laparoscopy;   Procedure: Laparotomy
16 Not yet recruiting NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: NUC-1031 500 mg;   Drug: NUC-1031 750mg
17 Recruiting Sentinel Node Detection in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Sentinel Node
Intervention: Procedure: Injection of radioactive tracer combined with Patent Blue
18 Recruiting Genes Contributing to Hereditary Ovarian Cancer in African American Women and BRCA1/2 Wildtype Families
Condition: Ovarian Cancer
Intervention:
19 Recruiting Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer
Condition: Recurrent Platinum Resistant Ovarian Cancer
Intervention: Drug: cediranib and olaparib
20 Recruiting Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Apatinib;   Drug: Etoposide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.